Novartis And Gsk Announced The Launch Of A Collaboration To Support High-Quality Scientific Research Investigating The Link Between Genetic Diversity Across Different Regions In Africa And Its Potential Impact On Response To Drug Therapeutics.The Project Africa Genomic Research Approach For Diversity And Optimizing Therapeutics (Gradient), With A Combined Funding Commitment Of Gbp 2.8 Million (Us$ 3.6 Million) Over Five Years, Calls On African Researchers To Submit Robust Research Proposals On The Relevance Of African Genetic Diversity To The Treatment Of Malaria And Tuberculosis (Tb).Lutz Hegemann, M.D., Chief Operating Officer For Global Health At Novartis Said: &Ldquo;Novartis Has A Long-Standing Commitment To Improving And Extending The Lives Of Patients Around The World. Our Efforts Include Seeking Innovative Ways To Improve The Standard Of Care Where Possible. This Is Why We Are Excited By This Important Collaboration On Scientific Research On Genetic Diversity In Africa. It Has The Potential To Improve The Efficacy And Tolerability Of Current And Future Medicines, Starting With Two Of The Most Deadly Diseases, Malaria And Tuberculosis. In Alignment With Our Ongoing Efforts To Strengthen Scientific Capabilities In Lower-Resource Settings, This Project Also Provides Opportunities For Training Young African Scientists In The Use Of Advanced Research Methodologies And Mentoring On Drug Development.&Rdquo;Pauline Williams, Senior Vice President Global Health Pharma At Gsk Said: &Ldquo;At Gsk, Human Genetics Is A Core Pillar Of Our R&Amp;D Strategy. Genetic Diversity Is Greater In Africa Than In Any Other Continental Population Resulting In Some African Patients Having Varying Response To Treatments. We Are Excited To Launch Project Africa Gradient Which Aims To Catalyze The Best Science In The Continent To Optimize Treatment Responses For Malaria And Tuberculosis, Two Infectious Diseases That Disproportionately Affect African Populations.&Rdquo;Prof. Glenda Gray, Samrc President And Ceo, Said: &Ldquo;It Is Exciting To See More And More Global Partners Taking Interest In The Challenges Of Africa. We Are Delighted That Partners Are Now Seeking To Address The Challenges Of Africa By Their Quest To Understand The Fundamental Differences Between Genetics Of Africa And The Rest Of The World.&Rdquo;As A First Step, Researchers Based At Universities, Science Councils And Other Public Research Organizations Across Africa Are Invited To Express Their &Lsquo;Intent To Submit&Rsquo; Through The Samrc Website. Final Award Recipients Are Expected To Be Announced By End Of 2021.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!